M F13
Pill imprint M F13 has been identified as Felodipine extended release 10 mg.
Felodipine is used in the treatment of high blood pressure; raynaud's syndrome; angina pectoris prophylaxis and belongs to the drug class calcium channel blocking agents. Risk cannot be ruled out during pregnancy.
Felodipine 10 mg is not subject to the Controlled Substances Act.
See also related documents.
Felodipine extended release Images
- Imprint:
-
M
F13 - Strength:
- 10 mg
- Color:
- Blue
- Size:
- 11.00 mm
- Shape:
- Round
- Availability:
- Prescription only
- Inactive Ingredients:
- butylated hydroxyanisole
butylated hydroxytoluene
silicon dioxide
hypromellose
microcrystalline cellulose
polydextrose
polyethylene glycol
povidone
sodium stearyl fumarate
titanium dioxide
FD&C Blue No. 2
FD&C Yellow No. 6
- Drug Class:
- Calcium channel blocking agents
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- N - Not a controlled drug
- Manufacturer:
- Mylan Pharmaceuticals Inc.
- National Drug Code (NDC):
- 00378-5013
| NDC Code | Manufacturer / Repackager |
|---|---|
| 51079-0468 | UDL Laboratories Inc |
Note: Inactive ingredients may vary.
Advertisement
More Felodipine Extended Release resources
- Felodipine (Wolters Kluwer)
- felodipine (Cerner Multum)
- felodipine (Micromedex) - Includes Dosage Information
- Felodipine (AHFS DI)
- Felodipine (FDA)
- Felodipine (Wolters Kluwer)
Search Again
